Btg Pactual Global Asset Management LTD Biogen Inc. Call Options Transaction History

Btg Pactual Global Asset Management LTD

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2022 Nov 09, 2022	BUY	$194.69 - $268.46 $4.87 Million - $6.71 Million	25,000 New	25,000 $6.68 Million
Q2 2019 Aug 13, 2019	SELL	$219.29 - $241.72 $6.58 Million - $7.25 Million	-30,000 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$216.71 - $338.96 $6.5 Million - $10.2 Million	30,000 New	30,000 $7.09 Million
Q2 2018 Aug 14, 2018	SELL	$257.52 - $306.91 $6.95 Million - $8.29 Million	-27,000 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$260.13 - $367.91 $7.02 Million - $9.93 Million	27,000 New	27,000 $697,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Btg Pactual Global Asset Management LTD, based on Form 13F filings with the SEC.

Stay updated on Btg Pactual Global Asset Management LTD with notifications on news.